These findings imply that ESCs transfected with PD‐L1 nb or GM‐CSF‐peptides positively impact effector and memory T cell expansion while decreasing exhausted T cells and MDSCs, thereby improving the anti‐tumor effects of ESC‐based vaccines. This evidence concerns the gene CD274 and neoplasm.